Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
05.01.26
/
50%
€20.00
Target price
05.01.27
€44.47
Performance (%)
49.85%
Price
09.07.26
€30.33
Summary
This prediction is currently active. With a performance of 49.85% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 05.01.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 3.368% | 3.368% |
| iShares Core DAX® | -1,78 % | 2,48 % |
| iShares Nasdaq 100 | 1,52 % | 3,29 % |
| iShares Nikkei 225® | 1,08 % | 7,04 % |
| iShares S&P 500 | 0,93 % | 3,25 % |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Guggenheim from $64.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€22.10
08.05.26
08.05.26
€36.67
08.05.27
08.05.27
35.52%
09.07.26
09.07.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€32.00
20.06.25
20.06.25
€55.59
20.06.26
20.06.26
-26.03%
21.06.26
21.06.26